Steven Lo

Chief Executive Officer at VAXART, INC.

Net worth: 339 015 $ as of 2026-06-29

60 year

80 connections

Health Technology

Consumer Services

Health Services

Profile

Steven Lo is President, Chief Executive Officer & Director at Vaxart, Inc. since 2024.
Formerly, Mr. Lo was Chief Executive Officer & Director at Valitor, Inc. from 2022 to 2024; President, Chief Executive Officer & Director at Zosano Pharma Corp.
from 2019 to 2022; Chief Commercial Officer at Puma Biotechnology, Inc. from 2015 to 2019; Chief Commercial Officer & Senior Vice President at Corcept Therapeutics, Inc. from 2013 to 2015; Senior Director-Oncology Marketing at Genentech, Inc. from 1997 to 2010; Principal at Kaiser Permanente Washington Health Research Institute; and Member at Roche Group.
Education includes graduate studies at the University of Southern California and undergraduate studies at the University of California, Davis.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
VAXART, INC. 0.23%	2026-05-25	560,356 ( 0.23% )	339 015 $	2026-06-29

Steven Lo active positions

Companies	Position	Start
VAXART, INC.	Chief Executive Officer	2024-03-17

All active positions of Steven Lo

Former positions of Steven Lo

Companies	Position	End
Valitor, Inc. Valitor, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops novel methods of modifying therapeutic proteins	Chief Executive Officer	2024-02-29
ZOSANO PHARMA CORPORATION	Chief Executive Officer	2022-07-31
PUMA BIOTECHNOLOGY, INC.	Corporate Officer/Principal	2019-10-03
CORCEPT THERAPEUTICS INCORPORATED	Corporate Officer/Principal	2015-09-03
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples	Corporate Officer/Principal	-

See the detail of Steven Lo's experience

Training of Steven Lo

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Steven Lo's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples	Health Technology
Corcept Therapeutics, Inc. Corcept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of drugs which treat severe metabolic, oncologic and neuropsychiatric disorders	Health Technology
Kaiser Permanente Washington Health Research Institute Kaiser Permanente Washington Health Research Institute Hospital/Nursing ManagementHealth Services Provides healthcare plans and services	Health Services
University of Southern California University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Roche Group Roche Group Real Estate DevelopmentFinance Manages real estate properties	Finance
University of California, Davis University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Zosano Pharma Corp. Zosano Pharma Corp. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that specializes in the systemic administration of therapeutics	Health Technology
Puma Biotechnology, Inc. Puma Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a development stage company which develops biopharmaceuticals used for the treatment of cancer	Health Technology
Vaxart, Inc. Vaxart, Inc. BiotechnologyHealth Technology Develops vaccines	Health Technology
Valitor, Inc. Valitor, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops novel methods of modifying therapeutic proteins	Health Technology